Mike Montemarano, Associate Editor 03.16.21
Nutrition21, LLC announced that Cara Cesario, PhD, has joined the company as vice president of Manufacturing and Product Development. Cesario earned her B.S. in Chemistry from Stonehill College and PhD in Organic Chemistry from The University of Notre Dame, and is an author on 10 peer-reviewed publications and inventor of seven issued patents.
For the past six years, Cesario served as Chief Scientific Officer at Sweet Defeat and developed products formulated to reduce sugar cravings, prior to which she was a product manager at Thermo Fisher Scientific, managing consumable product portfolios for mass spectrometry. Earlier in her career, she synthesized novel cancer therapeutics at OSI Pharmaceuticals.
Cesario will work directly with Nutrition21 president Joe Weiss, and chief science officer, Jim Komorowski, to optimize the production of Nutrition21’s branded ingredients. In addition, she will expand the use of new dosage forms and bring new product innovations to the market, as well as other related technical services.
“Nutrition21 has a great reputation for science and innovation, which are two important aspects of a successful organization. I look forward to working with the research and development, marketing, and sales teams to deliver the innovation and results our customers are looking for,” Cesario said.
“We are excited to welcome a professional like Cara to our team and look forward to what her expertise will bring to Nutrition21,” Komorowski said. “She will be essential in driving our innovation forward and providing outstanding technical support to our customers.”
Mike Montemarano has been the Associate Editor of Nutraceuticals World since February 2020. He can be reached at mmontemarano@rodmanmedia.com.
For the past six years, Cesario served as Chief Scientific Officer at Sweet Defeat and developed products formulated to reduce sugar cravings, prior to which she was a product manager at Thermo Fisher Scientific, managing consumable product portfolios for mass spectrometry. Earlier in her career, she synthesized novel cancer therapeutics at OSI Pharmaceuticals.
Cesario will work directly with Nutrition21 president Joe Weiss, and chief science officer, Jim Komorowski, to optimize the production of Nutrition21’s branded ingredients. In addition, she will expand the use of new dosage forms and bring new product innovations to the market, as well as other related technical services.
“Nutrition21 has a great reputation for science and innovation, which are two important aspects of a successful organization. I look forward to working with the research and development, marketing, and sales teams to deliver the innovation and results our customers are looking for,” Cesario said.
“We are excited to welcome a professional like Cara to our team and look forward to what her expertise will bring to Nutrition21,” Komorowski said. “She will be essential in driving our innovation forward and providing outstanding technical support to our customers.”
Mike Montemarano has been the Associate Editor of Nutraceuticals World since February 2020. He can be reached at mmontemarano@rodmanmedia.com.
